A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo for Smoking Cessation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
The primary purpose of this study is to evaluate the safety and efficacy of varenicline given for a twelve week treatment period in comparison with placebo for smoking cessation.
Epistemonikos ID: 4edf599f81099ad7219eef7f8945bd73f85c0688
First added on: May 04, 2024